Related Experiment Video
Updated: Jul 17, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Fast-track surgery in infants and children
Marc Reismann1, Mirja von Kampen, Birgit Laupichler
1Department of Pediatric Surgery, Hanover Medical School, 30625 Hanover, Germany.
Journal of Pediatric Surgery
|January 9, 2007
Summary
Fast-track surgery is feasible in pediatric patients, significantly reducing hospital stays for procedures like pyeloplasty and appendectomy. This approach offers excellent patient comfort and outcomes.
Area of Science:
- Pediatric Surgery
- Surgical Outcomes
- Enhanced Recovery Pathways
Background:
- Fast-track surgery protocols are not widely established for pediatric populations.
- Investigating the feasibility of these protocols is crucial for improving pediatric surgical care.
Purpose of the Study:
- To assess the feasibility of implementing fast-track surgical concepts in pediatric patients.
- To evaluate the impact of fast-track protocols on hospitalization duration and patient comfort.
Main Methods:
- Prospective study of 159 pediatric patients undergoing various surgical procedures (pyeloplasty, appendectomy, etc.).
- Implementation of fast-track protocols: immediate postoperative feeding, mobilization, and opioid-sparing analgesia.
- Exclusion criteria: relevant comorbidities, reoperations, perforated appendicitis.
- Comparison of hospital stay with German Diagnosis-Related Groups (DRG) data.
Main Results:
- 71% of patients (113/159) were successfully treated with fast-track protocols without complications.
- Mean hospital stay for fast-track patients was significantly shorter (2.3 days) compared to DRG data across all procedures.
- High patient and parent satisfaction (96%) reported excellent comfort levels.
Conclusions:
- Fast-track surgical concepts are highly feasible in pediatric surgery.
- These protocols lead to significantly reduced hospital stays and high patient comfort.
- Further adoption of fast-track surgery in pediatric care is recommended.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...